权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

The 7th International Conference on Head and Neck Cancer

第七届国际头颈癌会议

基本信息

批准号：
7486677
负责人：
Jeffrey Nicholas Myers
金额：
$ 2万
依托单位：
UNIVERSITY OF TX MD ANDERSON CAN CTR
依托单位国家：
美国
项目类别：
财政年份：
2008
资助国家：
美国
起止时间：
2008-05-02 至 2009-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7486677
关键词：
American American Society of Clinical Oncology Area Chemoprevention Clinical Investigator Communities Dental Developed Countries Developing Countries Development Diagnostic Imaging Discipline Ensure Environment Familiarity Funding Future Head and Neck Cancer Head and Neck Surgery Head and neck structure Image Immunologist Immunology International Lead Medical Oncology Mental Health Molecular Molecular Genetics Nurse&apos s Role Nutritionist Oncologist Operative Surgical Procedures Organ Outcome Pain Participant Pathogenesis Patients Quality of life Radiation Oncology Radiation therapy Radiology Specialty Radiology, Head, Neck Rehabilitation therapy Reporting Research Research Personnel San Francisco Schedule Series Social Workers Societies Specialist Speech Pathologist Students Therapeutic Travel Tumor Cell Biology cancer care chemotherapy design functional outcomes gene therapy head and neck cancer patient medical specialties oncology symposium treatment program

项目摘要

DESCRIPTION (provided by applicant): The 7th International Conference on Head and Neck Cancer (SICHNCa) is the next scheduled conference in a series held every four years. The international conferences are the most important international interdisciplinary conferences focused, in a single meeting, on topics related to head and neck cancer. These topics include molecular genetics, tumor cell biology, immunology, gene therapy, organ-sparing surgery, radiology and imaging, radiotherapy, chemotherapy, chemoprevention, and quality of life issues. The conference is designed 1) to facilitate discussion among practitioners, trainees, and researchers with an emphasis on how collaborative, multi-disciplinary treatment and rehabilitation can lead to the best oncologic, functional and quality of life outcomes for head and neck cancer patients; 2) to bring together clinical investigators, geneticists, immunologists, and molecular and cellular biologists to share recent advances in head and neck cancer, identify needed areas of future research and disseminate this information to the larger community of investigators in related fields. The participation of four societies representing the disciplines of Medical Oncology (American Society for Clinical Oncology), Radiation Oncology (American Society of Therapeutic Radiation Oncology), Diagnostic Imaging (American Society of Head and Neck Radiology and Head and Neck Surgery (American Head and Neck Society) will ensure educational interaction within and between specialties that can strengthen multi-disciplinary collaborative relationships. Project Narrative: The 7th International Conference on Head and Neck Cancer to be held July 19-23, 2008 in San Francisco, CA is designed to facilitate discussion among practitioners, trainees, and researchers with an emphasis on how collaborative, multi-disciplinary treatment and rehabilitation can lead to the best oncologic, functional and quality of life outcomes for head and neck cancer patients. Objectives for the meeting include 1) to further understanding in the current environment in head and neck cancer care and research within and between the multiple disciplines represented; 2) to recognize the important role of nurses, speech pathologists, audiologists, nutritionists, social workers, pain specialists, mental health practitioners, physical therapists, dental oncologists in achieving maximal functional outcomes and proper functional assessment and reporting of functional results of new treatments programs, and 3) to provide familiarity with emerging research breakthroughs that are helping us to better understand the pathogenesis and treatment of head and neck cancer. In order for this information to be disseminated as equitably as possible to practitioners of head and neck oncology around the world so that their patients may potentially benefit from the most current developments in the field, these funds will be used to support the travel expenses of students, residents, fellows and other participants from around the world including developing nations.

描述（由申请人提供）：第七届国际头颈癌会议（SICHNCa）是每四年举行一次的系列会议中的下一个预定会议。国际会议是最重要的国际跨学科会议，集中在一次会议上，讨论与头颈癌有关的主题。这些主题包括分子遗传学，肿瘤细胞生物学，免疫学，基因治疗，器官保留手术，放射学和成像，放疗，化疗，化学预防和生活质量问题。该会议的目的是1）促进从业人员，学员和研究人员之间的讨论，重点是如何协作，多学科治疗和康复可以导致头颈癌患者的最佳肿瘤，功能和生活质量的结果; 2）汇集临床研究人员，遗传学家，免疫学家，以及分子和细胞生物学家分享头颈癌的最新进展，确定未来研究所需的领域，并将此信息传播给相关领域的更大研究人员社区。代表医学肿瘤学（美国临床肿瘤学会），放射肿瘤学（美国治疗放射肿瘤学会），诊断成像（美国头颈放射学会）和头颈外科（美国头颈学会）学科的四个学会的参与将确保专业内部和之间的教育互动，可以加强多学科的合作关系。项目叙述：第七届头颈癌国际会议将于2008年7月19日至23日在加利福尼亚州旧金山弗朗西斯科举行，旨在促进从业人员，学员和研究人员之间的讨论，重点是如何合作，多学科的治疗和康复可以导致头颈癌患者的最佳肿瘤，功能和生活质量的结果。会议的目标包括：1）在当前环境下，进一步了解头颈癌的护理和研究内部和之间的多学科代表; 2）认识到护士、言语病理学家、听力学家、营养学家、社会工作者、疼痛专家、心理健康从业人员、物理治疗师的重要作用，牙科肿瘤学家在实现最大的功能结果和适当的功能评估和报告新的治疗方案的功能结果，以及3）提供对新兴研究突破的熟悉，这些突破有助于我们更好地了解头颈癌的发病机制和治疗。为了使这些信息尽可能公平地传播给世界各地的头颈部肿瘤学从业人员，使他们的患者可能从该领域的最新发展中受益，这些资金将用于支持来自世界各地的学生，居民，研究员和其他参与者的旅行费用，包括发展中国家。